The vast majority of image-detected breast abnormalities are diagnosed by percutaneous
core needle biopsy (CNB) in contemporary practice. For frankly malignant lesions …

Introduction Current standard of care for patients diagnosed with “low-risk” ductal carcinoma
in situ (DCIS) involves surgical resection. Ongoing phase III clinical trials are hoping to …

Surgical excision of breast intraductal papilloma (IDP) without atypia diagnosed on core
needle biopsy (CNB) is controversial as the risk of upgrade to malignant lesions is not well …

Rationale and Objective To determine the diagnostic yield of various imaging tests used to
evaluate nipple discharge. Materials and Methods A single institution, IRB-approved …

Background Papillomas of the breast pose challenges for treatment decisions as their risk
for transformation to breast cancer is low but not negligible. To spare low-risk patients the …

Papillary neoplasms of the breast are a heterogeneous group of tumors characterized by
fibrovascular cores lined by epithelium, with or without myoepithelial cells. Papillary …

Previously reported upgrade rates for benign breast intraductal papilloma (IDP) are widely
variable. However, many previous studies have failed to consider radiologic‐pathologic …

Objective To compare outcomes between benign intraductal papillomas diagnosed on core
need biopsy that were excised (BIP-E) versus those that were followed-up (BIP-F) at our …

Currently, the optimal treatment approach for breast benign intraductal papilloma (IDP)
diagnosed via biopsy remains uncertain. There is ongoing debate regarding the feasibility of …

Purpose High-risk breast pathology is a breast cancer risk factor for which timely treatment is
crucial. Nurse navigation programs have been implemented to minimize delays in patient …